Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.rbmo.2020.06.013 http://scihub22266oqcxt.onion/10.1016/j.rbmo.2020.06.013 32660814!7316047!32660814     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32660814&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Reprod+Biomed+Online 2020 ; 41 (3): 361-364 Nephropedia Template TP {{tp|p=32660814|t=2020. Assisted reproduction and thromboembolic risk in the COVID-19 pandemic |pdf=|usr=}}{{32660814}} gab.com Text Assisted reproduction and thromboembolic risk in the COVID-19 pandemic JO: Reprod Biomed Online http://www.kidney.de/pget.php?&tw=1&pmid=32660814 #FOAvip The COVID-19 pandemic has significantly increased mortality in many countries, with the number of infected cases increasing exponentially worldwide. One of the main determining factors of the poor prognosis in these patients is the development of coagulopathy. Moreover, it is well known that assisted reproductive technology procedures confer a risk of thromboembolic complications. This commentary analyses specific aspects coexisting between the thrombotic risk described during virus infection and that reported in the context of assisted reproduction treatments. Based on known pathophysiological aspects of virus infection and of ovarian stimulation, there are common elements that deserve to be taken into account. In the present context, any risk of hyperstimulation should be avoided. Gonadotrophin-releasing hormone agonist triggering should be mandatory in high-responder patients and/or those with COVID-19 infection. In both cases, the cycle should be segmented. A proposal is made for the use of prophylactic low molecular weight heparin not only in those cases in which oocyte retrieval has been performed, but also in those in which cancellation has been decided. In addition, endometrial preparation for frozen-thawed embryo transfers should use the transdermal route in order to minimize the higher thrombotic risk associated with the oral route. Twit Text FOAVip Assisted reproduction and thromboembolic risk in the COVID-19 pandemic ????Reprod Biomed Online http://www.kidney.de/pget.php?&tw=1&pmid=32660814 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32660814 #FOAvip English Wikipedia <ref>{{Cite pmid|32660814}}</ref> Assisted reproduction and thromboembolic risk in the COVID-19 pandemic #MMPMID32660814 Fabregues F; Penarrubia J Reprod Biomed Online 2020[Sep]; 41 (3): 361-364 PMID32660814show ga The COVID-19 pandemic has significantly increased mortality in many countries, with the number of infected cases increasing exponentially worldwide. One of the main determining factors of the poor prognosis in these patients is the development of coagulopathy. Moreover, it is well known that assisted reproductive technology procedures confer a risk of thromboembolic complications. This commentary analyses specific aspects coexisting between the thrombotic risk described during virus infection and that reported in the context of assisted reproduction treatments. Based on known pathophysiological aspects of virus infection and of ovarian stimulation, there are common elements that deserve to be taken into account. In the present context, any risk of hyperstimulation should be avoided. Gonadotrophin-releasing hormone agonist triggering should be mandatory in high-responder patients and/or those with COVID-19 infection. In both cases, the cycle should be segmented. A proposal is made for the use of prophylactic low molecular weight heparin not only in those cases in which oocyte retrieval has been performed, but also in those in which cancellation has been decided. In addition, endometrial preparation for frozen-thawed embryo transfers should use the transdermal route in order to minimize the higher thrombotic risk associated with the oral route. |*Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Embryo Transfer/methods[MESH] |Female[MESH] |Heparin, Low-Molecular-Weight/administration & dosage[MESH] |Humans[MESH] |Oocyte Retrieval[MESH] |Ovarian Hyperstimulation Syndrome/complications/prevention & control/virology[MESH] |Ovulation Induction/adverse effects[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH] |Pregnancy[MESH] |Reproductive Techniques, Assisted/*adverse effects[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]Assisted reproduction and thromboembolic risk in the COVID-19 pandemic(epmc).pdf DeepDyve Pubget Overpricing